Peter Santer

Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study

Christin Stegemann, Raimund Pechlaner, Peter Willeit et al. · Circulation · 2014 · 575 citations · Full text

Life Sciences, Biochemistry, Cardiology +16

Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease

Stefan Kiechl, Georg Schett, Gregor K. Wenning et al. · Circulation · 2004 · 507 citations · Full text

Medicine, Cardiology, Bone Metabolism +14

Role of Lipoprotein(a) and Apolipoprotein(a) Phenotype in Atherogenesis

Florian Kronenberg, Martina F. Kronenberg, Stefan Kiechl et al. · Circulation · 1999 · 290 citations

Medicine, Cardiology, Clinical Cardiology +13

Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)

Peter Willeit, Stefan Kiechl, Florian Kronenberg et al. · Journal of the American College of Cardiology · 2014 · 280 citations

Public Health, Biostatistics, Clinical Epidemiology +13

Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes

Peter Willeit, Philipp Skroblin, Alexander R. Moschen et al. · Diabetes · 2016 · 256 citations · Full text

Medicine, Biochemistry, Endocrinology +17